Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Abivax reports effect of ABX-464 on HIV blood reservoir in phase IIa study

May 3, 2017

NIAID grant supports Lyndra's development of ultra-long acting HIV therapy

May 3, 2017

Hetero Research Foundation identifies antiviral agents

May 2, 2017

GlaxoSmithKline identifies novel IDO-1 inhibitors

April 12, 2017

GlaxoSmithKline divulges novel anti-HIV compounds

April 7, 2017

ViiV Healthcare divulges benzoazepine derivatives

March 30, 2017

First-in-human data presented for tenofovir disoproxil orotate

March 21, 2017

GeoVax Labs collaborates with American Gene Technologies on functional cure for HIV

March 15, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

March 14, 2017

Theratechnologies acquires commercial rights to ibalizumab in E.U. and other countries

March 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...